Literature DB >> 31821550

Laparoscopic colposuspension for urinary incontinence in women.

Jawad Freites1, Fiona Stewart2, Muhammad Imran Omar3,4, Atefeh Mashayekhi2, Wael I Agur5.   

Abstract

BACKGROUND: Laparoscopic colposuspension was one of the first minimal access operations for treating stress urinary incontinence in women, with the presumed advantages of shorter hospital stays and quicker return to normal activities. This Cochrane Review was last updated in 2010.
OBJECTIVES: To assess the effects of laparoscopic colposuspension for urinary incontinence in women; and summarise the principal findings of relevant economic evaluations of these interventions. SEARCH
METHODS: We searched the Cochrane Incontinence Specialised Register (22 May 2019), which contains trials identified from CENTRAL, MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, CINAHL, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings. SELECTION CRITERIA: Randomised controlled trials of women with urinary incontinence that included laparoscopic surgery in at least one arm. DATA COLLECTION AND ANALYSIS: We independently extracted data from eligible trials, assessed risk of bias and implemented GRADE. MAIN
RESULTS: We included 26 trials involving 2271 women. Thirteen trials (1304 women) compared laparoscopic colposuspension to open colposuspension and nine trials (412 women) to midurethral sling procedures. One trial (161 women) compared laparoscopic colposuspension with one suture to laparoscopic colposuspension with two sutures; and three trials (261 women) compared laparoscopic colposuspension with sutures to laparoscopic colposuspension with mesh and staples. The majority of trials did not follow up participants beyond 18 months. Overall, there was unclear risk of selection, performance and detection bias and generally low risk of attrition and reporting bias. There is little difference between laparoscopic colposuspension using sutures and open colposuspension for subjective cure within 18 months (risk ratio (RR) 1.04, 95% confidence interval (CI) 0.99 to 1.08; 6 trials, 755 women; high-quality evidence). We are uncertain whether laparoscopic colposuspension using mesh and staples is better or worse than open colposuspension for subjective cure within 18 months (RR 0.75, 95% CI 0.61 to 0.93; 3 trials, 362 women; very low-quality evidence) or whether there is a greater risk of repeat continence surgery with laparoscopic colposuspension. Laparoscopic colposuspension may have a lower risk of perioperative complications (RR 0.67, 95% CI 0.47 to 0.94; 11 trials, 1369 women; low-quality evidence). There may be similar or higher rates of bladder perforations with laparoscopic colposuspension (RR 1.72, 95% CI 0.90 to 3.29; 10 trials, 1311 women; moderate-quality evidence). Rates for de novo detrusor overactivity (RR 1.29, 95% CI 0.72 to 2.30; 5 trials, 472 women) and voiding dysfunction (RR 0.81, 95% CI 0.50 to 1.31; 5 trials, 507 women) may be similar but we are uncertain due to the wide confidence interval. Five studies reported on quality of life but we could not synthesise the data. There may be little difference between laparoscopic colposuspension using sutures and tension-free vaginal tape (TVT) for subjective cure within 18 months (RR 1.01, 95% CI 0.88 to 1.16; 4 trials, 256 women; low-quality evidence) or between laparoscopic colposuspension using mesh and staples and TVT (RR 0.71, 95% CI 0.55 to 0.91; 1 trial, 121 women; low-quality evidence). For laparoscopic colposuspension compared with midurethral slings, there may be lower rates of repeat continence surgery (RR 0.40, 95% CI 0.04 to 3.62; 1 trial, 70 women; low-quality evidence) and similar risk of perioperative complications (RR 0.99, 95% CI 0.60 to 1.64; 7 trials, 514 women; low-quality evidence) but we are uncertain due to the wide confidence intervals. There may be little difference in terms of de novo detrusor overactivity (RR 0.80, 95% CI 0.34 to 1.88; 4 trials, 326 women; low-quality evidence); and probably little difference in terms of voiding dysfunction (RR 1.06, 95% CI 0.47 to 2.41; 5 trials, 412 women; moderate-quality evidence) although we are uncertain due to the wide confidence interval. Five studies reported on quality of life but we could not synthesise the data. No studies reported on bladder perforations. Low-quality evidence indicates that there may be higher subjective cure rates within 18 months with two sutures compared to one suture (RR 1.37, 95% CI 1.14 to 1.64; 1 trial, 158 women). Comparing one suture and two sutures, one suture may have lower rates of repeat continence surgery (RR 0.35, 95% CI 0.01 to 8.37; 1 trial, 157 women) and similar risk of perioperative complications (RR 0.88, 95% CI 0.45 to 1.70) but we are uncertain due to the wide 95% CIs. There may be higher rates of voiding dysfunction with one suture compared to two sutures (RR 2.82; 95% CI 0.30 to 26.54; 1 trial, 158 women; low-quality evidence), but we are uncertain due to the wide confidence interval. This trial did not report bladder perforations, de novo detrusor overactivity or quality of life. We are uncertain whether laparoscopic colposuspension with sutures is better or worse for subjective cure within 18 months compared to mesh and staples (RR 1.24, 95% CI 0.96 to 1.59; 2 trials, 180 women; very low-quality evidence) or in terms of repeat continence surgery (RR 0.97, 95% CI 0.06 to 14.91; 1 trial, 69 women; very low-quality evidence). Laparoscopic colposuspension with sutures may increase the number of perioperative complications compared to mesh and staples (RR 1.94, 95% CI 1.09 to 3.48; 3 trials, 260 women; low-quality evidence) but rates of de novo detrusor overactivity may be similar (RR 0.72, 95% CI 0.17 to 3.06; 2 trials, 122 women; low-quality evidence), however, we are uncertain due to the wide confidence interval. None of the studies reported bladder perforations, voiding dysfunction or quality of life. AUTHORS'
CONCLUSIONS: The data indicate that, in terms of subjective cure of incontinence within 18 months, there is probably little difference between laparoscopic colposuspension and open colposuspension, or between laparoscopic colposuspension and midurethral sling procedures. Much of the evidence is low quality, meaning that a considerable degree of uncertainty remains about laparoscopic colposuspension. Future trials should recruit adequate numbers, conduct long-term follow-up and measure clinically important outcomes. A brief economic commentary identified three studies. We have not quality-assessed them and they should be interpreted in light of the findings on clinical effectiveness.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31821550      PMCID: PMC6903454          DOI: 10.1002/14651858.CD002239.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  64 in total

1.  The long-term outcome of laparoscopic colposuspension: a 10-year cohort study.

Authors:  Simon Barr; Fiona M Reid; Carolyn E North; Gordon Hosker; Anthony R B Smith
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-01-10

Review 2.  Mid-urethral sling operations for stress urinary incontinence in women.

Authors:  Abigail A Ford; Lynne Rogerson; June D Cody; Patricia Aluko; Joseph A Ogah
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

3.  [Endoscopic colposuspension ("retziusscopy" versus laparoscopy). An effective extension of the surgical spectrum of stress incontinence?].

Authors:  D Wallwiener; E M Grischke; S Rimbach; A Maleika; M Kaufmann; G Bastert
Journal:  Geburtshilfe Frauenheilkd       Date:  1995-05       Impact factor: 2.915

Review 4.  Laparoscopic versus open surgical techniques for ventral or incisional hernia repair.

Authors:  Stefan Sauerland; Maren Walgenbach; Brigitte Habermalz; Christoph M Seiler; Marc Miserez
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

Review 5.  Laparoscopic colposuspension for urinary incontinence in women.

Authors:  N M Dean; G Ellis; P D Wilson; G P Herbison
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence.

Authors:  Cynelle M Kunkle; Jennifer L Hallock; Xiaohan Hu; Joan Blomquist; Stephen F Thung; Erika F Werner
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 May-Jun       Impact factor: 2.091

Review 7.  The financial burden of stress urinary incontinence among women in the United States.

Authors:  Erin C Chong; Aqsa A Khan; Jennifer T Anger
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 8.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Haroon Rehman; Carlos A Bezerra; Homero Bruschini; June D Cody; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

9.  Cost of stress urinary incontinence: a claims data analysis.

Authors:  Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig Kinchen; Peter Sun
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 10.  Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues.

Authors:  Roslin Botlero; Donna M Urquhart; Susan R Davis; Robin J Bell
Journal:  Int J Urol       Date:  2008-03       Impact factor: 3.369

View more
  4 in total

Review 1.  Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews.

Authors:  Alex Todhunter-Brown; Christine Hazelton; Pauline Campbell; Andrew Elders; Suzanne Hagen; Doreen McClurg
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

2.  Burch colposuspension for stress urinary incontinence: a 14-year prospective follow-up.

Authors:  Yang Ye; Yuan Wang; Weijie Tian; Zhibo Zhang; Shuo Liang; Xiaochen Song; Jianbin Guo; Qianqian Gao; Honghui Shi; Zhijing Sun; Juan Chen; Jinghe Lang; Lan Zhu
Journal:  Sci China Life Sci       Date:  2022-01-19       Impact factor: 10.372

3.  Risk factors of postpartum stress urinary incontinence in primiparas: What should we care.

Authors:  Jiejun Gao; Xinru Liu; Yan Zuo; Xiaocui Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

4.  The Efficacy and Mid-term Durability of Urethral Sphincter Injections of Platelet-Rich Plasma in Treatment of Female Stress Urinary Incontinence.

Authors:  Ching-Hsiang Chiang; Hann-Chorng Kuo
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.